Bacteriological profile and antimicrobial resistance of blood culture isolates

Iranian Journal of Clinical Infectious Diseases

Volumn 4, Issue 2, 2009, Pages 87-95

  Barati, Mitra ^a   Taher, Mahshid Talebi ^a   Abasi, Roshanak ^a   Zadeh, Mona Mohammad ^a   Barati, Mardjan ^a   Shamshiri, Ahmad Reza ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial susceptibility pattern; Bloodstream infection; Nosocomial infection

Indexed keywords

CIPROFLOXACIN; OXACILLIN; VANCOMYCIN;

ACINETOBACTER; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; EPSILOMETER TEST; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFANT; IRAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

EID: 77953375563     PISSN: 17355109     EISSN: 20081081     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Diekma DJ, Beekman SE, Chapin KC, Morel KA, Munson E, Doern GV. Epidemiology and outcome of nosocomial and community onset bloodstream infection. J Clin Microbiol 2003;41:3655-60.
2. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
3. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENETRY antimicrobial surveillance program (United states and Canada, 1997). Antimicrob Agents Chemother 1998;42(7):1762-70.
4. Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 2003;41(1):495-97.
5. Laupland KB, Davis HD, Church DL, Louie TJ, Dool JS, Zygun DA, et al. Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study. Infection 2004;2:59-64.
6. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, Sauver JL, Wilson WR, et al. Age- and sex-associated trends in bloodstream infection. Arch Intern Med 2007;167:834-39.
7. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENETRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infec Dis 2004;8(1):25-79.
8. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients. Chest 2003; 123:1615-24.
9. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENETRY antimicrobial surveillance program (1997-2002). Diagn Microbiol Infect Dis 2004;50:59-69.
10. Sligl W, Taylor G, Brindley PG. Five years of nosocomial gram-negative bacteria in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006;10:320-25.
11. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41(4):848-54.
12. Hadadi A, Rasoulinejad M, Maleki Z, Yonesian M, Shirani A, Kourorian Z. Antimicrobial resistance pattern of gram-negative bacilli of nosocomial origin at 2 university hospital in Iran. Diagn Microbiol Infect Dis 2008;60:301-5.
13. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34(2):344-53.
14. Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systemic surveillance cultures in an adult intensive care unit. Crit Care Med 2006;34:653-59.
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definition conference. Intensive Care Med 2003;29:530-8.
16. th ed. Philadelphia: Lippincott Williams & Wilkins. 2006;p: 100-2.
17. NCCLS 2003. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. Wayne, PA, NCCLS.
18. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing; thirteen informational supplement. Document M100-S13. Wayne, PA, 2003.
19. Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination. Arch Pathol Lab Med 2005;129:1222-25.
20. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003; 47(25):1681-88.
21. Douglas MW, Lum G, Roy J, Fisher DA, Anstey NM, Currie BJ. Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Trop Med Int Health 2004; 9(7):795-804.
22. Sucu N, Caylan R, Aydin K, Yilmaz G, Aktoz B, Koksal I. Prospective evaluation of blood cultures in medical faculty hospital of Blacksea Technical University. Mikrobiyoloji Bulteni 2005;39:455-64.
23. Garg A, Anupurba S, Garg J, Goyal RK, Sen MR. Bacteriological profile and antimicrobial resistance of blood culture isolates from a university hospital. JIACM 2007; 8(2):139-43.
24. Munoz-Price L, Weinstein RA. Acinetobacter infection. N Eng J Med 2008;358:1271-81.
25. Tien HC, Batted A, Bryce EA, Fuller J, Mulvey M, Bernard K, et al. Multi-drug resistant acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect Dis 2007;7:95.
26. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 2007;35:2538-4.6
27. Houang ET, Chu YW, Lenung CM, Chu KY, Berlau J, NG KC, et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol.2001;39(1):228-34.
28. Segal SC, Zaoutis TE, Kagen J, Shah SS. Epidemiology of and risk factors for acinetobacter species blood stream infection in children. Pediatr Infect Dis 2007;26(10):920-6.
29. Ranjbar R, Sadeghifard N, Ahmadi A, Izadi M, Zaeimi-Yazdi J, Ghasemi A, et al. Antimicrobial susceptibility and AP-PCR typing of acinetobacter spp. strains. Iranian Journal of Public Health 2007;36(4):50-56.
30. McGowan JE. Resistance in non-fermenting gramnegative bacteria: multidrug resistance to the maximum. Am J Med 2006;119(6A):529-36.
31. Albrecht MA, Griffith ME, Murray CK, Chung KK, Horvath EE, Ward JA, et al. Impact of acinetobacter infection on the mortality of burn patients. J Am Coll Surg 2006;203:546-50.
32. Ling TK, Ying CM, Lee CC, Liu ZK. Comparison of antimicrobial resistance of acinetobacter baumannii clinical isolates from Shanghi and Hong Kong. Med Princ Pract 2005;14(5):338-41.
33. Echeverria MJ, Lopez de Goicoechea MJ, Avarza R, Vecino Y, Lazpita MA, Ibarretxebea AB, et al. In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolate of acinetobacter baumannii. Enferm Infecc Microbiol Clin 1997;15(6):319-22.
34. Shi ZY, Liu PY, Lau Y, Liu Y, Hu BS, Shir J-M. Antimicrobial susceptibility of clinical isolates of acinetobacter baumannii. Diagn Microbiol Infect Dis 1996;24(2):81-5.
35. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002;34:634-40.
36. Heinemann B, Wispelinghoff H, Edmond M, Seifert H. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined acinetobacter baumannii strains. Antimicrob Agents Chemother 2000;44(8);2211-13.
37. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998;129(3):182-9.
38. Karimi Shahidi M, Dabag Mohammadi AG, Mohajer Iravani B, Meigoni MA. The epidemiology and susceptibility study of inpatient blood cultures in Amir Alam Hospital 1998-2000. Journal of Tehran University of Medical Sciences 2002;6(1):31-37. (Abstract)
39. Moniri R, Mosayebi Z, Movahedian AH, Mossavi GhA. Increasing trend of antimicrobial drug-resistance in pseudomonas aeruginosa causing septicemia. Iranian Journal of Public Health 2006;35(1):58-62.
40. Halstead DC, Abid J, Dowzicky MJ. Antimicrobial susceptibility among acinetobacter calcoaceticus-baumannii complex and enterobacteriaceae collected as part of the tigecycline evaluation and surveillance trial. J Infect 2007;55(1):49-57.
41. Jones NR, Sader HS, Fritsche TR, Pottumarthy S. Comparison of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENETRY antimic40-robial surveillance program (1998-2004). Diagn Microbiol Infect Dis 2007;57:109-16.
42. Nakhjavani FA, Mirsalehian A, Hamidian M, Kazemi A, Mirafshar M, Jabalameli F. Antimicrobial susceptibility testing for E.coli strains to fluoroquinoloes, in urinary tract infections. Iranian Journal of Public Health 2007;36(1):89-92.
43. Poiata A, Tuchilus C, Ambarus A, Teodor A, Teodorescu I, Luca V, et al. Antimicrobial susceptibility of Staphylococcus aureus isolated from colonized hospital personnel. Rev Med Chir Soc Med Nat Iasi 2006;110(3):723-6.